These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 7855218)
1. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Ginski MJ; Witkin JM Psychopharmacology (Berl); 1994 May; 114(4):573-82. PubMed ID: 7855218 [TBL] [Abstract][Full Text] [Related]
2. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. Geter-Douglass B; Witkin JM Psychopharmacology (Berl); 1997 Sep; 133(1):43-50. PubMed ID: 9335079 [TBL] [Abstract][Full Text] [Related]
3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253 [TBL] [Abstract][Full Text] [Related]
4. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Witkin JM; Steele TD; Sharpe LG J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180 [TBL] [Abstract][Full Text] [Related]
5. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice. Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141 [TBL] [Abstract][Full Text] [Related]
6. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Scalzo FM; Burge LJ Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359 [TBL] [Abstract][Full Text] [Related]
7. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites. Kamei H; Kameyama T; Nabeshima T Eur J Pharmacol; 1996 Mar; 299(1-3):21-8. PubMed ID: 8901003 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan. Zapata A; Gasior M; Geter-Douglass B; Tortella FC; Newman AH; Witkin JM Pharmacol Biochem Behav; 2003 Jan; 74(2):313-23. PubMed ID: 12479950 [TBL] [Abstract][Full Text] [Related]
9. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists. Wlaź P Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291 [TBL] [Abstract][Full Text] [Related]
10. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Geter-Douglass B; Witkin JM Psychopharmacology (Berl); 1999 Oct; 146(3):280-9. PubMed ID: 10541728 [TBL] [Abstract][Full Text] [Related]
11. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors. Löscher W; Hönack D J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice. Starr MS; Starr BS Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205 [TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception. DeLander GE; Wahl JJ Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511 [TBL] [Abstract][Full Text] [Related]
14. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. Koek W; Colpaert FC J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806 [TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. Löscher W; Hönack D J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593 [TBL] [Abstract][Full Text] [Related]
16. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Chou YC; Liao JF; Chang WY; Lin MF; Chen CF Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839 [TBL] [Abstract][Full Text] [Related]
17. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex. Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125 [TBL] [Abstract][Full Text] [Related]
18. Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors. Mori A; Noda Y; Mamiya T; Miyamoto Y; Nakajima A; Furukawa H; Nabeshima T Behav Brain Res; 2001 Feb; 119(1):33-40. PubMed ID: 11164523 [TBL] [Abstract][Full Text] [Related]
19. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs. Brent PJ Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818 [TBL] [Abstract][Full Text] [Related]
20. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Irifune M; Shimizu T; Nomoto M; Fukuda T Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]